Le Lézard
Classified in: Health, Business
Subject: TNM

Medical Technology Associates (MTA) is Pleased to Announce the Acquisition of GasMedix


PINELLAS PARK, Fla., Jan. 19, 2022 /PRNewswire/ -- Medical Technology Associates, Inc. (MTA) is pleased to announce the acquisition of GasMedix, LLC headquartered in Evansville, Indiana. Founded in 2003, GasMedix is a leader in the Midwest market for medical gas services, equipment, and compliance testing with a strong, proven track record of service excellence.

"We are thrilled and honored to have GasMedix join the MTA team. GasMedix is a great strategic fit, both culturally and geographically," said Val Marks, CEO of MTA. "The management team and employees have grown an exceptional business and fostered a culture of patient life safety and outstanding customer service," Marks said. "We look forward to building an even brighter future together!"

Jim Quirk, founder and president of GasMedix, stated, "I want to thank our entire dedicated team for building GasMedix into the company that it is today. I'm incredibly excited about MTA's shared values and commitment to GasMedix employees, our engineer partners, mechanical installer partners and our medical facility clients. With MTA's robust infrastructure and support team, GasMedix, as a division of MTA, is well positioned to be unparalleled in the medical gas sales and service industry."

GasMedix will deepen MTA's Midwest presence and extend the team's ability to deliver standardized medical gas testing to the largest of Healthcare Systems. Leveraging MTA's infrastructure, GasMedix will now have access to MTA's very robust and flexible reporting software platform for the benefit of employees and customers. "Together, we will broaden Gas Medix's service offerings, expand their footprint and leverage technology to drive customer success," Marks said. "It's a real win/win for the customers and the employees."

MTA is a national leader in the Medical Gas and Controlled Environment industries providing compliance solutions for patient life safety across the U.S. As a single source provider, MTA delivers a wide range of Medical Gas, Environmental Monitoring and Controlled Environment testing and equipment solutions to healthcare facilities centered on service excellence.

GasMedix operates a world-class medical gas service organization with a laser focus on patient safety and facility compliance, serving national hospital groups, regional medical centers, and surgery centers throughout Indiana, Illinois, Ohio, and Kentucky. The company's key management team will continue in their current roles, and founder Jim Quirk will remain active through the transition. Wes Reed and Don Baer remain the key contacts for the region.

Media Contact:
Valeri Marks
Medical Technology Associates, Inc.
727 548-8600
[email protected]

SOURCE Medical Technology Associates


These press releases may also interest you

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...



News published on and distributed by: